These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26096850)

  • 1. EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion.
    Poschau M; Dickreuter E; Singh-Müller J; Zscheppang K; Eke I; Liersch T; Cordes N
    Radiother Oncol; 2015 Sep; 116(3):510-6. PubMed ID: 26096850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
    Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures.
    Eke I; Cordes N
    Radiother Oncol; 2011 Jun; 99(3):279-86. PubMed ID: 21704406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures.
    Rossow L; Eke I; Dickreuter E; Cordes N
    Oncol Rep; 2015 Jul; 34(1):469-76. PubMed ID: 26004008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.
    Hehlgans S; Lange I; Eke I; Cordes N
    Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.
    Koppenhagen P; Dickreuter E; Cordes N
    Radiother Oncol; 2017 Sep; 124(3):370-378. PubMed ID: 28578803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition.
    Eke I; Dickreuter E; Cordes N
    Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells.
    Zscheppang K; Kurth I; Wachtel N; Dubrovska A; Kunz-Schughart LA; Cordes N
    J Cancer; 2016; 7(6):736-45. PubMed ID: 27076856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling.
    Kim YJ; Jung K; Baek DS; Hong SS; Kim YS
    Oncogene; 2017 May; 36(18):2543-2552. PubMed ID: 27797376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.
    Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N
    Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
    Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
    Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells.
    Steglich A; Vehlow A; Eke I; Cordes N
    Cancer Lett; 2015 Feb; 357(2):542-8. PubMed ID: 25497870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
    Feng Y; Gao S; Gao Y; Wang X; Chen Z
    Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
    Liu C; Qu L; Zhao C; Shou C
    J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab-mediated ADCC activity is correlated with the cell surface expression level of EGFR but not with the KRAS/BRAF mutational status in colorectal cancer.
    Seo Y; Ishii Y; Ochiai H; Fukuda K; Akimoto S; Hayashida T; Okabayashi K; Tsuruta M; Hasegawa H; Kitagawa Y
    Oncol Rep; 2014 May; 31(5):2115-22. PubMed ID: 24626880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.
    Zhou J; Lv L; Lin C; Hu G; Guo Y; Wu M; Tian B; Li X
    Mol Med Rep; 2015 Oct; 12(4):5407-14. PubMed ID: 26151111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment.
    Brockmueller A; Girisa S; Kunnumakkara AB; Shakibaei M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells.
    Eke I; Schneider L; Förster C; Zips D; Kunz-Schughart LA; Cordes N
    Cancer Res; 2013 Jan; 73(1):297-306. PubMed ID: 23074283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.
    Cordes N; Frick S; Brunner TB; Pilarsky C; Grützmann R; Sipos B; Klöppel G; McKenna WG; Bernhard EJ
    Oncogene; 2007 Oct; 26(48):6851-62. PubMed ID: 17471232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.